Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
JIB

Non-DEHP and Phthalate-Free Tubing Now Available for Routine Laboratory Applications

By BiotechDaily International staff writers
Posted on 27 Aug 2013
A major European manufacturer of high-performance flexible tubing and other plastic laboratory products has introduced a bio-based, phthalate-free product for use in routine laboratory applications.

Saint-Gobain Performance Plastics (Paris, France) the manufacturer of Tygon high-performance flexible tubing, has recently introduced a bio-based, phthalate-free product. DEHP Di(2-ethylhexyl phthalate), a common plasticizer, has been removed from existing Tygon formulations.

The next-generation DEHP- and phthalate-free Tygon S3 tubing is made with a bio-based plasticizer and the product’s new sustainable formulations are biodegradable and deliver superior pump life. For example, Tygon S3 E-3603 non-DEHP tubing was specially formulated for resistance to flex-fatigue and abrasion. In many peristaltic pump applications, it outlasts the original R-3603 by a factor of three to one. As tubing for an instrumentation connection, vent, drain and other general laboratory applications, Tygon S3 E-3603 Tubing offers superior life, which minimizes the labor and expense of replacement.

New Tygon S3 formulations include Tygon S3 E-3603 General Laboratory Tubing and Tygon S3 E-LFL Long Flexible Life Tubing. Tygon R-1000 has also been replaced by Tygon E-1000, soft and flexible non-DEHP tubing.

“The change to non-DEHP tubing is integral to the company’s continued efforts toward safety, compliance, and sustainability,” said Katia May, laboratory market manager for Saint-Gobain Performance Plastics. “Saint-Gobain is the first manufacturer to remove DEHP and phthalates from tubing products for laboratory applications and beyond. We are committed to providing superior, smart, safe, and sustainable flexible tubing with unsurpassed performance.”

Related Links:

Saint-Gobain


comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Alternative splicing produces two protein isoforms (Photo courtesy of Wikimedia Commons).

Key Regulator of Cancer-Inducing Alternative Splicing Identified

Cancer researchers have identified the splicing factor RBM4 (RNA-binding protein 4) as a key determinant in processes that prevent tumor development and spread. RBM4 is known to be crucial to gene splicing... Read more

Drug Discovery

view channel

Ibuprofen May Restore Immune Function in Older Individuals

New research suggests that macrophages from the lungs of old mice respond differently to infections than those of young mice, and ibuprofen given to the mice reversed these changes. New research using lab mice suggests that the solution to more youthful immune function might already be a common over-the-counter pain reliever.... Read more

Therapeutics

view channel
Image: Hair follicle (blue) being attacked by T cells (green) (Photo courtesy of Christiano Lab/Columbia University Medical Center).

Hair Restoration Method Clones Patients’ Cells to Grow New Hair Follicles

Researchers have developed of a new hair restoration approach that uses a patient’s cells to grow new hair follicles. In addition, the [US] Food and Drugs Administration (FDA) recently approved a new drug... Read more

Lab Technologies

view channel
Image: Leica Microsystems launches the inverted research microscope platform Leica DMi8 (Photo courtesy of Leica Microsystems).

New Inverted Microscope Designed to Readily Adapt to Changing Research Demands

A new inverted microscope for biotech and other life science laboratories was designed to readily accommodate modifications and upgrades to allow it to keep current with changing research demands and interests.... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.